Mayim Bialik detailed severe side effects from a single GLP-1 injection in an essay published June 5, 2026, describing weeks of debilitating gastrointestinal symptoms that left her unable to keep down water and requiring IV fluids.
Quick Facts
- Bialik took one dose of the lowest dose of a synthetic GLP-1 after her doctor suggested it might ease symptoms from her Graves’ disease and other autoimmune conditions
- Side effects included explosive diarrhea, violent sulfur burps, sneezing attacks, cramping, bloating, and full-body aching lasting multiple days
- In one clinical trial, nausea, vomiting, and diarrhea occurred in nearly three-quarters of semaglutide users
- More than 4,000 Americans have filed lawsuits against GLP-1 manufacturers over severe side effects
The 50-year-old actress and neuroscientist wrote in her essay for The Free Press that despite years of struggling with Graves’ disease, connective tissue disease, mast cell activation syndrome, Sjögren’s syndrome, and dysautonomia, she was not prepared for what the GLP-1 would do to her body.
“To say I had an adverse reaction would be somewhat of an understatement,” Bialik wrote. “Explosive, uncontrollable diarrhea. Sulfur burps so violent they left me afraid to open my mouth in public. Sneezing attacks every time I tried to eat or drink.”
Bialik described being unable to keep down even small sips of water, with symptoms so severe that a nurse came to her home to administer IV fluids. She noted that both her doctor and the nurse seemed unsurprised by the severity of her reaction.
The side effects extended far beyond the initial injection. Weeks after the single shot, Bialik experienced ongoing gastrointestinal issues, including an incident where she had to pull off the highway to use a bathroom. A gastroenterologist confirmed her reaction was dramatic but not unusual, and warned that the medication should only be used for life-compromising obesity and its related health consequences.
According to USA Today, gastrointestinal issues remain among the most commonly reported GLP-1 side effects, including nausea, vomiting, diarrhea, constipation, and bloating. Fatigue, dizziness, headaches, and injection site reactions are also documented. Rarer but more serious risks include pancreatitis, gallbladder disease, acute kidney injury, and thyroid changes.
Bialik’s experience aligns with clinical data. In The Free Press article, she cited a clinical trial showing that nausea, vomiting, and diarrhea occurred in nearly three-quarters of semaglutide users. The article also noted that more than 4,000 Americans have filed lawsuits against GLP-1 manufacturers, with some alleging severe gastrointestinal injury, permanent vision loss, or wrongful death.
Sources
- USA Today — reported on Bialik’s GLP-1 experience, side effects, and medical context from her essay; provided Mayo Clinic information on GLP-1 risks and benefits
- The Free Press — published Bialik’s full essay detailing her GLP-1 reaction, medical history, and clinical trial data on GLP-1 side effects
